摩根士丹利：中国医疗保健_2025 年国家医保药品目录和商业保险药品目录启动谈判

June 26, 2025 02:15 PM GMT China Healthcare | Asia Pacific 2025 NRDL and Commercial Insurance Drug List to Start Negotiation Key Takeaways Eligibility: Eligibility for NRDL negotiations is similar to previous years, including new drugs or indications approved before June 30, 2025, rare disease and pediatric drugs, etc. In addition, drugs eligible for the Commercial Insurance List include: 1) new drugs approved during 1/1/2020-6/30/2025; 2) rare disease drugs. Timeline: The NRDL negotiations may be moved ahe ...